Periodontics

How Periodontitis Bacteria Borrow Growth Molecules From Their Neighbors?

The human body is filled with beneficial bacteria. But even the kindest and most harmless is fraught with danger. For example bacteria, Veillonella parvula...

Dr. Rockson Samuel

Dr. Rockson Samuel

Founder & Chief Dentist · Indira Dental Clinic; DentalReach

3 min read18,921 views
  • professional education
  • microbiology
  • dentistry
  • gingivitis
  • oral microbiome
  • periodontitis
  • pathogenic bacteria
  • bacterial interaction
  • Periodontics
  • Clinical & Academic Article

The human body is filled with beneficial bacteria. But even the kindest and most harmless is fraught with danger. For example bacteria, Veillonella parvula contribute to the growth and reproduction of bacteria Porphyromonas gingivalis, which in turn cause gum disease. This conclusion was made by a study by specialists from the University of Buffalo.

The aim of the study is to understand how Porphyromonas gingivalis forms colonies in the oral cavity. The fact that the pathogen can not produce its own molecule of growth until it reaches a large population in the oral cavity microbiome. It was necessary to understand how the pathogenic bacterium, whose population in a healthy oral cavity is negligible, achieves its insidious goal. It turned out that pathogens use the growth molecules secreted by Veillonella parvula, which are not considered to be pathogenic.

Since there are very few Porphyromonas gingivalis in a healthy organism, they are very difficult to reproduce. However, when oral hygiene becomes unsatisfactory, plaque builds up and the bacteria Veillonella parvula secrete many growth molecules that stimulate the proliferation of Porphyromonas gingivalis.

According to statistics, 47% of people over the age of 30 have some form of periodontitis. Understanding the reproduction process of Porphyromonas Gingivalis will lead to targeted treatments for the disease, says Patricia Diaz, M.D., Ph.D., lead research researcher, and Professor of Empire Innovation at the University of Buffalo School of Dental Medicine.

“After studying Porphyromonas gingivalis for almost two decades, they concluded that the bacteria required a large population to grow, but it was not clear what processes lead to this. but the specific processes that lead to this phenomenon have not been fully understood, ”says Diaz. “Successfully targeting Veillonella Parvula with medicinal agents will prevent the P. gingivalis colony from growing to pathological levels,” says Dr. Diaz.

In the study, the authors tested the effect of growth molecules secreted by microorganisms in the mouth on Porphyromonas gingivalis. As part of the work, 5 types of bacteria that are common in gingivitis were considered.

Among the 5 bacteria examined, only one species, the bacteria Veillonella Parvula, promoted the growth of the number of bacteria Porphyromonas gingivalis, regardless of the strain. When the Veillonella Parvula bacteria were removed from the experimental medium, the growth of pathogens stopped. However, with a small amount of Parvula bacteria, no stimulation of the growth and reproduction of pathogenic bacteria was observed.

The data suggest that the link is unidirectional, as V. parvula has not received any obvious benefit from the exchange of growth molecules.

“Both bacteria interact at different levels, but only the P. gingivalis pathogens benefit from this relationship,” Diaz says. She also noted the bacteria secrete hemes - a popular source of iron for P. gingivalis bacteria .

“This relationship brings negative results not only at the initial stage of periodontitis. It is known that in the presence of V. parvula bacteria, P. gingivalis pathogens contribute to more intense bone destruction, which is a sign of more severe forms of periodontitis, ”says George Hadjishengallis, MD, Ph.D., research co-investigator, and Thomas W. Evans at the University of Pennsylvania School of Dental Medicine.

“It's unclear if the chemistry of the growth molecules released by the two species of bacteria is identical,” Diaz says. "Much more work is required to determine their chemical similarity for the further development of therapeutic agents."

Source: sciencedirect.com

References

  1. [1]European Federation of Periodontology. S3-Level Clinical Practice Guidelines for Periodontology EFP Clinical Guidelines. 2020. Available at: source
  2. [2]Sanz M, Herrera D, Kebschull M, et al.. Treatment of stage I-III periodontitis: The EFP S3 level clinical practice guideline Journal of Clinical Periodontology. 2020. Available at: source

Written by

Dr. Rockson Samuel

Dr. Rockson Samuel

Founder & Chief Dentist · Indira Dental Clinic; DentalReach

Dr. Rockson Samuel is a dental surgeon, healthcare content strategist, and Founder and Chief Dentist of Indira Dental Clinic in Vellore, Tamil Nadu. He provides comprehensive general and family dental care with professional interests in endodontics, implant dentistry, clear aligner therapy, digital dentistry, preventive care and patient education. A graduate of K.G.F. College of Dental Sciences and Hospital under Rajiv Gandhi University of Health Sciences, he also has formal training in management and digital marketing. As Community Leader at DentalReach, he contributes to dental publishing, professional education, international media partnerships and the development of evidence-informed resources for dentists.